Beyond matrix stiffness: targeting force-induced cancer drug resistance
Trends in Cancer · 2023-11 · 9 (11) · 937-954
DOI: 10.1016/j.trecan.2023.07.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2023-11. Verfasst von Maria Kalli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus. Hauptthemen laut MEDLINE: Mechanotransduction, Cellular, Neoplasms. Die Arbeit wurde bisher 181-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, European Research Council.
Abstract (Originalsprache)
During tumor progression, mechanical abnormalities in the tumor microenvironment (TME) trigger signaling pathways in cells that activate cellular programs, resulting in tumor growth and drug resistance. In this review, we describe mechanisms of action for anti-cancer therapies and mechanotransduction programs that regulate cellular processes, including cell proliferation, apoptosis, survival and phenotype switching. We discuss how the therapeutic response is impacted by the three main mechanical TME abnormalities: high extracellular matrix (ECM) composition and stiffness; interstitial fluid pressure (IFP); and elevated mechanical forces. We also review drugs that normalize these abnormalities or block mechanosensors and mechanotransduction pathways. Finally, we discuss current challenges and perspectives for the development of new strategies targeting mechanically induced drug resistance in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus.
- Department of Bioengineering and Hillman Cancer Center, University of Pittsburgh, PA, USA.
- Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus. Electronic address: tstylian@ucy.ac.cy.
- Department of Bioengineering and Hillman Cancer Center, University of Pittsburgh, PA, USA. Electronic address: ioz1@pitt.edu.
Förderung
- NCI NIH HHS
- NIBIB NIH HHS
- European Research Council
- National Institutes of Health
- Horizon 2020
- National Cancer Institute
- National Institute of Biomedical Imaging and Bioengineering
- University of Pittsburgh
Zitieren
APA
Kalli, M., Poskus, M. D., Stylianopoulos, T., & Zervantonakis, I. K. (2023). Beyond matrix stiffness: targeting force-induced cancer drug resistance. Trends in Cancer, 9(11), 937-954. https://doi.org/10.1016/j.trecan.2023.07.006
Vancouver
Kalli M, Poskus MD, Stylianopoulos T, Zervantonakis IK. Beyond matrix stiffness: targeting force-induced cancer drug resistance. Trends in Cancer. 2023;9(11):937-954. doi:10.1016/j.trecan.2023.07.006
BibTeX
@article{Kalli2023,
author = {Kalli, Maria and Poskus, Matthew D and Stylianopoulos, Triantafyllos and Zervantonakis, Ioannis K},
title = {Beyond matrix stiffness: targeting force-induced cancer drug resistance},
journal = {Trends in Cancer},
year = {2023},
volume = {9},
number = {11},
pages = {937--954},
doi = {10.1016/j.trecan.2023.07.006}
}
EUVIMED